Skip to main content
. 2016 Jul 6;14(3):1923–1932. doi: 10.3892/mmr.2016.5474

Figure 5.

Figure 5

Effects of LOXL2 silencing on hepatocellular carcinoma cell cycle distributions. (A) Representative histograms of flow cytometry and (B) histogram of percentage of different cell cycle phases in HepG2 cells. (C) Representative histograms of flow cytometry and (D) histogram of percentages of different cell cycle phases in SMMC-7721 cells. **P<0.01 vs. the control group. LOXL2, lysyl oxidase-like 2; siRNA, small interfering RNA.